FDA Authorizes Drug For High-Risk Hospitalized Patients With COVID-19

Reuters (11/10, Satija) reports “Sobi North America, a unit of Swedish Orphan Biovitrum AB, said on Thursday the U.S. Food and Drug Administration authorized its arthritis drug for treatment of high-risk hospitalized” patients with COVID-19. Anakinra (Kin...